Diana Paredes-Ruiz

7PUBLICATIONS
19CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Rheumatology and arthritisRegenerative medicine (incl. stem cells)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 20, 2026
Impact of belimumab on the utility of serological markers for assessing systemic lupus erythematosus activity.

|Apr 22, 2026
Efficacy of the Lupus-Cruces Nephritis protocol in different prognostic groups: a propensity score and cluster analysis.

|Oct 26, 2024
No Effect of Low-Dose Glucocorticoid Maintenance Therapy on Damage in SLE Patients in Prolonged Remission: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort.

Guillermo Ruiz-Irastorza, Diana Paredes-Ruiz, Luis Dueña-Bartolome

|Mar 26, 2024
Methylprednisolone Pulses and Prolonged Remission in Systemic Lupus Erythematosus: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort.

Guillermo Ruiz-Irastorza, Diana Paredes-Ruiz, Maria Herrero-Galvan

|Dec 19, 2023
Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus.

Diana Paredes-Ruiz, Daniel Martin-Iglesias, Guillermo Ruiz-Irastorza

|Oct 27, 2022
Clinical Differences and Outcomes of COVID-19 Associated Pulmonary Thromboembolism in Comparison with Non-COVID-19 Pulmonary Thromboembolism.

Santiago de Cossio, Diana Paredes-Ruiz, Covadonga Gómez-Cuervo

Pageof 2

Frequent Collaborators

4 joint publications

Guillermo Ruiz-Irastorza

3 joint publications

Víctor Moreno-Torres

2 joint publications

Luis Dueña-Bartolome

2 joint publications

Estibaliz Lazaro